Analysts See Drastic Change For This Particular Part Of Healthcare

The biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for the industry. While Moderna shares have remained volatile since then — down 23.5% Thursday after rising 177% Wednesday — the biotech ETF is doing its job as a diversified fund, keeping its one-day price moves to within 6%.